139 related articles for article (PubMed ID: 15935480)
1. Attenuation of the Fas-L independent B16BL6 melanoma lymphocidic capacity by H-2K class I molecules.
Kellman-Pressman S; Fishman D; Tsory S; Segal S
Immunol Lett; 2005 Sep; 100(2):146-52. PubMed ID: 15935480
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Li M; Muller J; Xu F; Hearing VJ; Gorelik E
Cancer Res; 1996 Oct; 56(19):4464-74. PubMed ID: 8813142
[TBL] [Abstract][Full Text] [Related]
3. B lymphocytes mediate Fas-dependent cytotoxicity in MRL/lpr mice.
Bonardelle D; Benihoud K; Kiger N; Bobé P
J Leukoc Biol; 2005 Nov; 78(5):1052-9. PubMed ID: 16204618
[TBL] [Abstract][Full Text] [Related]
4. Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.
Ryan AE; Shanahan F; O'Connell J; Houston AM
Cancer Res; 2005 Nov; 65(21):9817-23. PubMed ID: 16267003
[TBL] [Abstract][Full Text] [Related]
5. The role of MHC class I glycoproteins in the regulation of induction of cell death in immunocytes by malignant melanoma cells.
Fishman D; Irena B; Kellman-Pressman S; Karas M; Segal S
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1740-4. PubMed ID: 11172021
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous in vivo retrovirus-infected T and B cells, but not dendritic cells, mediate antigen-specific Fas ligand/Fas-dependent apoptosis of anti-retroviral CTL.
Rich RF; Cook WJ; Green WR
Virology; 2006 Mar; 346(2):287-300. PubMed ID: 16337984
[TBL] [Abstract][Full Text] [Related]
7. Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells.
Mohamood AS; Trujillo CJ; Zheng D; Jie C; Murillo FM; Schneck JP; Hamad AR
Int Immunol; 2006 Aug; 18(8):1265-77. PubMed ID: 16769751
[TBL] [Abstract][Full Text] [Related]
8. Fas receptor signaling is requisite for B cell differentiation.
Pasqualetto V; Vasseur F; Zavala F; Schneider E; Ezine S
J Leukoc Biol; 2005 Nov; 78(5):1106-17. PubMed ID: 16266974
[TBL] [Abstract][Full Text] [Related]
9. Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.
Kim M; Duty L; Herberman R; Gorelik E
Cell Immunol; 1994 May; 155(2):358-71. PubMed ID: 8181071
[TBL] [Abstract][Full Text] [Related]
10. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
11. Raising allo-restricted cytotoxic T lymphocytes by co-culture of murine splenocytes with autologous macrophage bearing the peptide/allo-major histococompatibility complex.
Chen X; Yan Y; Lu S; Weng X; Liang Z; Li J; Zhong M; Tang J; Xiao W; Sun W; Shen G; Wu X
Hum Immunol; 2009 Feb; 70(2):79-84. PubMed ID: 19100802
[TBL] [Abstract][Full Text] [Related]
12. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
13. Death of peripheral CD8+ T cells in the absence of MHC class I is Fas-dependent and not blocked by Bcl-xL.
Markiewicz MA; Brown I; Gajewski TF
Eur J Immunol; 2003 Oct; 33(10):2917-26. PubMed ID: 14515276
[TBL] [Abstract][Full Text] [Related]
14. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the expression of MHC class I glycoproteins by B16BL6 melanoma cells modulate insulin receptor-regulated signal transduction and augment [correction of augments] resistance to apoptosis.
Assa-Kunik E; Fishman D; Kellman-Pressman S; Tsory S; Elhyany S; Baharir O; Segal S
J Immunol; 2003 Sep; 171(6):2945-52. PubMed ID: 12960318
[TBL] [Abstract][Full Text] [Related]
16. In vivo reexpression of H-2 antigens in B16 melanoma cells.
Lollini PL; Colombo MP; De Giovanni C; Nicoletti G; Parmiani G; Prodi G; Nanni P
Exp Clin Immunogenet; 1985; 2(1):14-23. PubMed ID: 3939971
[TBL] [Abstract][Full Text] [Related]
17. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
Tashiro-Yamaji J; Kubota T; Yoshida R
Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
[TBL] [Abstract][Full Text] [Related]
18. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
Mandelboim O; Vadai E; Feldman M; Eisenbach L
Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
[TBL] [Abstract][Full Text] [Related]
19. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
[TBL] [Abstract][Full Text] [Related]
20. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
